Ultrastructural basis of enhanced antitumor cytotoxicity of cord blood-derived CTLs: A comparative analysis with peripheral blood and bone marrow

International Journal of Oncology

Volumn 37, Issue 3, 2010, Pages 645-653

  Clark, Erin M ^a   Joshi, Deepa S ^b   Grimm, Andrew B ^b   Joshi, Avadhut D ^a   Wang, Peng ^a   Joshi, Shantaram S ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b Millard North High School   (United States)

Author keywords

Antigen processing; Bone marrow; Cord blood; Dendritic cells; Peripheral blood; Ultrastructure

Indexed keywords

ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL HETEROGENEITY; CELL MATURATION; CELL ULTRASTRUCTURE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXIC LYMPHOCYTE; DENDRITIC CELL; ENDOSOME; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; PRIORITY JOURNAL; SCANNING TRANSMISSION ELECTRON MICROSCOPY; UMBILICAL CORD BLOOD;

ANTIGEN PRESENTATION; BONE MARROW CELLS; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FETAL BLOOD; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 77956527811     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000713     Document Type: Article

References (44)

1. Apperley JF: Umbilical cord blood progenitor cell transplantation. The International Conference Workshop on Cord Blood Transplantation. Bone Marrow Transplant. 14: 187-196, 1994.
2. Broxmeyer HE, Gluckman E, Auerbach A, Douglas GW, Friedman H, Cooper S, et al: Human umbilical cord blood: a clinically useful source of transplantable hematopoietic stem/progenitor cells. Int J Cell Cloning 8 (Supp. 1): S76-S91, 1990.
3. Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A, et al: Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 321: 1174-1178, 1989.
4. Schoemans H, Theunissen K, Maertens J, Boogaerts M, Verfaillie C and Wagner J: Adult umbilical cord blood transplantation: a comprehensive review. Bone Marrow Transplant 38: 83-93, 2006.
5. Theilgaard-Monch K, Raaschou-Jensen K, Palm H, et al: Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts. Bone Marrow Transplant 28: 1073-1082, 2001.
6. Gluckman E and Rocha V: Cord blood transplantation: state of the art. Hematologica 94: 451-454, 2009.
7. Reimann V, Creutzig U and Kogler G: Stem cells derived from cord blood in transplantation and regenerative medicine. Dtsch Arztebl Int 106: 831-836, 2009.
8. Schlechta B, Wiedermann D, Kittinger C, Jandrositz A, Bonaros NE, Humer JC, Preisegger K and Kocher AA: Ex-vivo expanded umbilical cord blood stem cells retain capacity for myocardial regeneration. Circ J 74: 188-194, 2010.
9. Roszek K and Komoszynski M: Regulation and direction of umbilical cord blood stem cells differentiation and their therapeutic application (Review). Postepy Hig Med Dosw (online) 62: 660-667, 2008.
10. Yu G, Borlongan CV, Stahl CE, Yu SJ, Bae E, Yang T, et al: Transplantation of human umbilical cord blood cells for the repair of myocardial infarction. Med Sci Monit 14: RA163-RA172, 2008.
11. Ichim TE, Solano F, Brenes R, Glenn E, Chan J, Chan K, et al: Placental mesenchymal and cord blood stem cell therapy for dilated cardiomyopathy. Reprod Biomed Online 16: 898-905, 2008. (Pubitemid 351865356)
12. Tse W, Bunting KD and Laughlin MJ: New insights into cord blood stem cell transplantation. Curr Opin Hematol 15: 279-284, 2008.
13. Haller MJ, Viener HL, Wasserfall C, Brusko T, Atkinson MA and Schatz DA: Autologous umbilical cord blood infusion for type 1 diabetes. Exp Hematol 36: 710-715, 2008.
14. Burt RK, Loh Y, Pearce W, Beohar N, Barr WG, Craig R, et al: Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA 299: 925-936, 2008.
15. Tse WW, Zang, SL, Bunting KD and Laughlin MJ: Umbilical cord blood transplantation in adult myeloid leukemia. Bone Marrow Transplant 41: 465-472, 2008.
16. Harris DT and Rogers I: Umbilical cord blood: a unique source of pluripotent stem cells for regenerative medicine. Curr Stem Cell Res Ther 2: 301-309, 2007.
17. Escobar A, López M, Serrano A, Ramirez M, Pérez C, Aguirre A, et al: Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients. Clin Exp Immunol 142: 555-568, 2005. (Pubitemid 41719853)
18. + progenitors and activated with type I interferon. J Immunother 28: 505-516, 2005.
19. Comoli P, Pedrazzoli P, Maccario R, Basso S, Carminati O, Labirio M, et al: Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes. J Clin Oncol 23: 8942-849, 2005.
20. Straathof KC, Bollard CM, Popat U, Huls MH, Lopez T, Morriss MC, et al: Treatment of nasopharyngeal carcinoma with Epstein-Barr virus-specific T lymphocytes. Blood 105: 1898-1904, 2005.
21. Schwartz JD and Beutler AS: Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials-II: systemic and local non-embolization-based therapies in unresectable and advanced hepatocellular carcinoma. Anticancer Drugs 15: 439-452, 2004.
22. Lee WC, Wang HC, Hung CF, Huang PF, Lia CR and Chen MF: Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial. J Immunother 28: 496-504, 2005. (Pubitemid 41232571)
23. Mu LJ, Kyte JA, Kvalheim G, Aamdal S, Dueland S, Hauser M, et al: Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients. Br J Cancer 93: 749-756, 2005.
24. Waeckerle-Men Y, Uetz-von Allmen E, Fopp M, von Moos R, Bahme C, Schmid H-P, et al: Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma. Cancer Immunol Immunother 55: 1524-1533, 2006.
25. Harris DT, LoCascio J and Besencon FJ: Analysis of the alloreactive capacity of human umbilical cord blood: implications for graft-versus-host disease. Bone Marrow Transplant 14: 545-553, 1994. (Pubitemid 24338479)
26. Joshi SS, Babushkina-Patz NN, Verbik DJ, Gross TG, Tarantolo SR, Kuszynski CA, et al: Antitumor activity of human umbilical cord blood cells: A comparative analysis with peripheral blood and bone marrow cells. Int J Oncol 13: 791-799, 1998.
27. Joshi SS, Vu E, Lovgren TR, Lorkovic M, Patel W, Todd GL, et al: Comparison of phenotypic and functional dendritic cells derived from human umbilical cord blood and peripheral blood mononuclear cells. J Hematother Stem Cell Res 11: 337-347, 2002.
28. Lovgren TR, Tarantolo SR, Evans C, Kuszynski CA and Joshi SS: Enhanced in vitro and in vivo cytotoxicity of umbilical cord blood cells against human breast cancer following activation with IL-15 and colony stimulating factors. In Vivo 16: 541-550, 2002. (Pubitemid 35469032)
29. Wang P, Munger CM, Joshi AD, Pirruccello SJ and Joshi SS: Cytotoxicity of cord blood derived Her2/neu-specific cytotoxic T lymphocytes against human breast cancer in vitro and in vivo. Breast Cancer Res Treat 83: 15-23, 2004.
30. Joshi AD, Clark EM, Wang P, Munger CM, Hegde GV, Sanderson S, et al: Immunotherapy of human neuroblastoma using umbilical cord blood-derived effector cells. J Neuroimmune Pharmacol 2: 201-212, 2007.
31. Verbik DJ, Jackson JD, Pirruccello SJ, Patil KD, Kessinger A and Joshi SS: Functional and phenotypic characterization of human peripheral blood stem cell harvests: a comparative analysis of cells from consecutive collections. Blood 85: 1964-1970, 1995.
32. Kessinger A and Armitage JO: The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood 77: 211-213, 1991.
33. Kraus MH, Popescu NC, Amsbaugh SC and King CR: Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J 6: 605-610, 1987.
34. Brossart P, Stuhler G, Flad T, Stevanovic S, Rammensee HG, Kanz L, et al: Her2/neu-derived peptides are tumor associated antigen expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes. Cancer Res 15: 732-738, 1998.
35. Munger CM, Vose JM and Joshi SS: Dendritic cell-based therapy for mantle cell lymphoma. Int J Oncol 28: 1337-1343, 2006.
36. Weir DM: Handbook of Experimental Immunology. 4th edition. Blackwell Scientific, Boston, 1986.
37. Banchereau J and Steinman RM: Dendritic cells and the control of immunity. Nature 392: 245-252, 1998.
38. + T cell tolerance. Immunity 18: 713-720, 2003.
39. Cella M, Sallusto F and Lanzavecchia A: Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9: 10-16, 1997. (Pubitemid 27095893)
40. Shutt DC, Daniels KJ, Caroloan EJ, Hill AC and Soll DR: Changes in the motility, morphology, and F-actin architecture of human dendritic cells in an in vitro model of dendritic cell development. Cell Motil Cytoskeleton 46: 200-202, 2000.
41. Verdijk P, de Ru AH, Hensbergen PJ, Mizuno K, Koerten HK, Koning F, et al: Morphological changes during dendritic cell maturation correlate with cofilin activation and translocation to the cell membrane. Eur J Immunol 34: 156-164, 2004.
42. Theunissen K and Verfaillie CM: A multifactorial analysis of umbilical cord blood, adult bone marrow and mobilized peripheral blood progenitors using the improved ML-IC assay. Exp Hematol 33: 165-172, 2005. (Pubitemid 40164898)
43. Wang JC, Doedens M and Dick JE: Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood 89: 3919-3924, 1997. (Pubitemid 27220934)
44. Setum CM, Serie JR and Hegre OD: Dendritic cell/lymphocyte clustering: morphologic analysis by transmission electron microscopy and distribution of gold-labeled MHC class II antigens by high-resolution scanning electron microscopy. Anat Rec 235: 285-295, 1993.